KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Contingent Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹5.55 Cr | ₹5.55 Cr | ₹5.49 Cr | ₹4.70 Cr | ₹4.93 Cr |
What is the latest Contingent Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
Year | Contingent Liabilities |
---|---|
Mar2023 | ₹5.55 Cr |
Mar2022 | ₹5.55 Cr |
Mar2021 | ₹5.49 Cr |
Mar2020 | ₹4.70 Cr |
Mar2019 | ₹4.93 Cr |
How is Contingent Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹5.55 Cr | 0.00 | |
Mar2022 | ₹5.55 Cr | 1.11 | |
Mar2021 | ₹5.49 Cr | 16.71 | |
Mar2020 | ₹4.70 Cr | -4.51 | |
Mar2019 | ₹4.93 Cr | - |
Compare Contingent Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹156.8 Cr | -0.6% | 13.7% | 4.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | -0.6% |
13.7% |
4.3% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses